Ligand Pharmaceuticals (LGND) Gross Profit (QoQ) (2011 - 2026)
Ligand Pharmaceuticals (LGND) Gross Profit (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - |
| 10 | Ligand Pharmaceuticals | 5.94 Bn | 5.17 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.51% |
| Dec 31, 2025 | -49.24% |
| Sep 30, 2025 | 149.69% |
| Jun 30, 2025 | 10.46% |
| Mar 31, 2025 | 1.27% |
| Dec 31, 2024 | -19.02% |
| Sep 30, 2024 | 27.80% |
| Jun 30, 2024 | 37.48% |
| Mar 31, 2024 | 6.18% |
| Dec 31, 2023 | -9.95% |
| Sep 30, 2023 | 18.97% |
| Jun 30, 2023 | -38.66% |
| Mar 31, 2023 | 39.95% |
| Dec 31, 2022 | -36.17% |
| Sep 30, 2022 | 19.34% |
| Jun 30, 2022 | 18.69% |
| Mar 31, 2022 | -28.37% |
| Dec 31, 2021 | -7.93% |
| Sep 30, 2021 | -0.03% |
| Jun 30, 2021 | 25.55% |